LINCOLN PHARMACEUTICALS LTD. - 531633 - Reg. 34 (1) Annual Report.
Regulation 34 (1) Annual Report06-09-2022
06-09-2022
LINCOLN PHARMACEUTICALS LTD. - 531633 - Notice Of 28Th Annual General Meeting Of The Company
Notice of 28th Annual General Meeting of the Company06-09-2022
LINCOLN PHARMACEUTICALS LTD. - 531633 - Announcement under Regulation 30 (LODR)-Newspaper Publication
Announcement under Regulation 30 (LODR)-Newspaper Publication26-08-2022
LINCOLN PHARMACEUTICALS LTD. - 531633 - Corporate Action Fixed Book Closure For Determining The Dividend If Approved At A.G.M.
Intimation of Book Closure26-08-2022
LINCOLN PHARMACEUTICALS LTD. - 531633 - Announcement Under Regulation 30 - Updates
This is to inform you that the Company is in process of identifying a suitable candidate for filing the position of Whole-time Company Secretary and Compliance Officer of the Company. The Board shall intimate the Stock exchanges upon appointment of Whole-time Company Secretary and Compliance Officer of the Company20-08-2022
LINCOLN PHARMACEUTICALS LTD. - 531633 - Announcement under Regulation 30 (LODR)-Newspaper Publication
Announcement under Regulation 30 (LODR)-Newspaper Publication10-08-2022
LINCOLN PHARMACEUTICALS LTD. - 531633 - Announcement under Regulation 30 (LODR)-Appointment of Statutory Auditor/s
Appointment of New Statutory Auditor subject to approval of members at Ensuing AGM as per the letter attached09-08-2022
LINCOLN PHARMACEUTICALS LTD. - 531633 - Announcement under Regulation 30 (LODR)-Change in Directorate
Details of appointment of Additional Director (Category: Whole Time Director) and resignation by Director is attached herewith09-08-2022
LINCOLN PHARMACEUTICALS LTD. - 531633 - FINANCIAL RESULTS FOR QUARTER ENDED 30.06.22
FINANCIAL RESULTS FOR QUARTER ENDED 30.06.2209-08-2022
LINCOLN PHARMACEUTICALS LTD. - 531633 - Board Meeting Outcome for OUTCOME BOARD MEETING
OUTCOME OF BOARD MEETING -RESULTS09-08-2022